Ohio Public Employees Retirement System (OPERS)
ZNTL icon

Ohio Public Employees Retirement System (OPERS)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,900
Closed -$48.2K – 2375
2025
Q3 		$48.2K Sell
31,900
-4,800
-13% -$7.2K ﹤0.01% 1949
2025
Q2 		$42.6K Buy
36,700
+28,576
+352% +$37.7K ﹤0.01% 1958
2025
Q1 		$12.9K Buy
+8,124
New +$17.5K ﹤0.01% 2254

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s ZNTL Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Zentalis Pharmaceuticals (ZNTL) in Q4 2025, closing a stake of 31,900 shares — an estimated $48.2K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ZNTL in Q1 2025 and held it in 3 quarters. The position peaked at $48.2K in Q3 2025. 86 funds tracked by Wall St. Rank hold ZNTL as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Zentalis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 31,900 Zentalis Pharmaceuticals shares in Q4 2025, an estimated $48.2K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Zentalis Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Zentalis Pharmaceuticals position peaked at $48.2K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.